investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Impact of Mitochondrial Genome Variation on Extreme Prostate Cancer Disparities
Mark D Adams
1 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Mark D Adams
J. Craig Venter Institute
Rockville, United States
Philip Venter
University of Limpopo
Polokwane, South Africa
Related projects
Anne E Cress
Human Prostate Cancer Metastasis and Laminin Binding Integrins
Prostate
Pathology
Serigne Magueye
Prostate Genetic Research Senegal (PROGRES)
Prostate
Pathology
Yan Xu
Role of Immune Cell OGR1 in Prostate Cancer Development and the Mechanisms Involved
Prostate
Pathology
Sue-Hwa Lin
Bone Microenvironment on Dormancy of Metastatic Prostate Cancer Cells
Prostate
Pathology
William Isaacs
Identifying Prostate Cancer Genes
Prostate
Pathology
Zijie Sun
A New Regulator for Wnt/beta-catenin Signaling and Prostate Tumorigenesis
Prostate
Pathology
Dario C Altieri
Control of Apoptosis in Cancer by Survivin
Prostate
Pathology
William Figg
Identify SNPs and Polymorphisms Involved in the Development of Prostate Cancer
Prostate
Pathology
William Figg
Using Clinical Pharmacology Principles to Develop New Anticancer Therapies
Prostate
Pathology